Posts by Jack Ellis
IP-skeptics charge that these inventions are little more than a way for pharmaceutical companies to cynically prolong patent life and maximize profits, without providing any meaningful innovation. …
is an Associate Researcher at Geneva Network and a freelance journalist.
Previously, Jack was the Asia-Pacific editor of Intellectual Asset Management magazine. He has also worked in a number of editorial and research roles covering intellectual property, the legal services market and the non-profit civic sector.
For more information or to contact Jack, please visit his Company Profile Page.